303 related articles for article (PubMed ID: 32764993)
1. Long Non-Coding RNAs in Drug Resistance of Breast Cancer.
Du T; Shi Y; Xu S; Wan X; Sun H; Liu B
Onco Targets Ther; 2020; 13():7075-7087. PubMed ID: 32764993
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications.
Wang Y; Bu N; Luan XF; Song QQ; Ma BF; Hao W; Yan JJ; Wang L; Zheng XL; Maimaitiyiming Y
Front Oncol; 2024; 14():1337579. PubMed ID: 38505593
[TBL] [Abstract][Full Text] [Related]
3. Role of Long Non-coding RNAs on Bladder Cancer.
Li HJ; Gong X; Li ZK; Qin W; He CX; Xing L; Zhou X; Zhao D; Cao HL
Front Cell Dev Biol; 2021; 9():672679. PubMed ID: 34422802
[TBL] [Abstract][Full Text] [Related]
4. The Role of Non-Coding RNAs in Breast Cancer Drug Resistance.
Tian JH; Liu SH; Yu CY; Wu LG; Wang LB
Front Oncol; 2021; 11():702082. PubMed ID: 34589423
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA
Cantile M; Di Bonito M; Cerrone M; Collina F; De Laurentiis M; Botti G
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397382
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
[TBL] [Abstract][Full Text] [Related]
8. The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer.
Malhotra A; Jain M; Prakash H; Vasquez KM; Jain A
Oncotarget; 2017 Dec; 8(66):110671-110684. PubMed ID: 29299178
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications.
Huang QY; Liu GF; Qian XL; Tang LB; Huang QY; Xiong LX
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31744046
[TBL] [Abstract][Full Text] [Related]
10. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
Chen C; Tang X; Liu Y; Zhu J; Liu J
Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer.
Campos-Parra AD; López-Urrutia E; Orozco Moreno LT; López-Camarillo C; Meza-Menchaca T; Figueroa González G; Bustamante Montes LP; Pérez-Plasencia C
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208633
[TBL] [Abstract][Full Text] [Related]
12. Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression.
Chen Q; Yang H; Zhu X; Xiong S; Chi H; Xu W
Front Genet; 2020; 11():566. PubMed ID: 32547604
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.
Liu Y; Ao X; Wang Y; Li X; Wang J
Front Oncol; 2022; 12():841411. PubMed ID: 35155266
[TBL] [Abstract][Full Text] [Related]
14. The Role of lncRNAs in the Distant Metastasis of Breast Cancer.
Wu Y; Shao A; Wang L; Hu K; Yu C; Pan C; Zhang S
Front Oncol; 2019; 9():407. PubMed ID: 31214490
[TBL] [Abstract][Full Text] [Related]
15. lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment.
Jin H; Du W; Huang W; Yan J; Tang Q; Chen Y; Zou Z
Mol Ther Nucleic Acids; 2021 Sep; 25():613-637. PubMed ID: 34589282
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
[TBL] [Abstract][Full Text] [Related]
18. Recent Progress in Characterizing Long Noncoding RNAs in Cancer Drug Resistance.
Zhao W; Shan B; He D; Cheng Y; Li B; Zhang C; Duan C
J Cancer; 2019; 10(26):6693-6702. PubMed ID: 31777598
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.
Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W
Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis profiles of long non-coding RNAs reveal potential biomarkers of drug resistance in lung cancer.
Xue W; Li L; Tian X; Fan Z; Yue Y; Zhang C; Ding X; Song X; Ma B; Zhai Y; Lu J; Kan Q; Zhao J
Oncotarget; 2017 Sep; 8(38):62868-62879. PubMed ID: 28968955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
